Company: ConvaTec Ireland. Description: Sterile gelling foam dressing consisting of a top polyurethane foam/film layer, a non-woven fibrous hydrofibre layer, and a thin non-adhesive layer or adhesive border. Presentation: Non-Adhesive: 7.5cm x 7.5cm-10, €20.70; 11cm x 11cm-10, €34.50; 15cm x 15 cm-5, €31.82; 20cm x 20cm-5, €47.54. Adhesive: 10cm x 10cm-10, €35.27; 14cm x 14cm-10, [...]
New indication for Pemetrexed (Alimta) in combination with cisplatin
Pemetrexed (Alimta) in combination with cisplatin is now indicated for the 1st line treatment of stage 3B / 4 non small cell lung cancer (NSCLC), other than predominantly squamous cell histology. In the largest ever phase three trial of chemotherapy-naive patients (n = 1725) suffering from stage 3B / 4 non small cell lung cancer, [...]
Hospira launches Octreotide solution for injection
Hospira Ireland Ltd is pleased to announce the launch of Octreotide, the first alternative to Sandostatin available in this market. Octreotide is available in a wide range of presentations: 0.05mg/ml, 0.1mg/ml, 0.2mg/ml, and 0.5mg/ml vials, offering choice, flexibility and convenience. The unique 0.2mg/ml presentation allows for increased flexibility, reduced wastage and cost-saving. If you are [...]
Innohep 10 pack launch
LEO Pharma wishes to announce that the following Innohep syringes have become available in packs of 10 from 1st April 2008: Innohep -10,000 IU in 0.5ml solution for injection, Innohep -14,000 IU in 0.7ml solution for injection and Innohep -18,000 IU in 0.9ml solution for injection. The syringes in packs of 2 and 6 will [...]
Apo Go 20mg/2ml discontinuation
Discontinuation of Feldene Topigel
Pfizer wishes to inform you that as a result of a change in the production facility for Feldene Topigel 30g OTC, this product was discontinued on 31st March 2008. There are no changes relating to Feldene gel 60g presentation. Should you require any further details, please do not hesitate to contact Alan Long at 086 [...]
Discontinuation of Mexitil ampoules and capsules
Boehringer Ingelheim wishes to announce that Mexitil (mexiletine hydrocholoride) ampoules (25mg/ml), Mexitil capsules (50mg) and Mexitil capsules (200mg) are being discontinued on June 30th 2008. We therefore recommend that you now consider suitable therapeutic alternatives for your patients currently receiving maintenance treatment with Mexitil capsules. In addition you should consider alternatives to Mexitil ampoules at [...]
Discontinuation of Rocaltrol 0.5mcg capsules
As part of a regular review of products in its pharmaceutical portfolio, Roche Products (Ireland) Ltd wish to inform you of the discontinuation of one of its products, Rocaltrol 0.5mcg capsules. Due to low demand for the Rocaltrol 0.5mcg presentation, marketing of the product will cease permanently on 30th June 2008 and stock remaining in [...]
Discontinuation of Symmetrel 100mg capsules
Novartis Ireland Ltd announces the discontinuation of Symmetrel 100mg capsules (amantadine hydrochloride) from May 30th 2008 due to cessation of production at the registered manufacturing site. Please be informed that alternative medicines are available for patients in this category. For further information please contact Novartis on (01) 2601255.